EIT Global Outreach
Health
Bridging the Horizon logo

Bridging the Horizon

Health

23 June 2026 | 10:00-12:00 CET | 11:00-13:00 IST

Co-Led By

Build a Winning Horizon Europe Consortium in Health

Bridging the Horizon is an exclusive virtual matchmaking series designed to catalyse the formation of high-level consortia in Horizon Europe. The programme serves as the strategic first stage of the wider Bridges 2026 hybrid initiative, specifically targeting the Health cluster.

This online event brings together a hand-picked group of researchers, academics, hospital representatives, and industry professionals from Europe and Israel to translate technical expertise into competitive project proposals. 

GET READY TO EXPAND YOUR HORIZONS!
Apply now
Thematic Focus
Health
The round table will focus on 5 selected open calls:
Leveraging Functional Genomics to Reveal Novel Targets for Cancer Treatment
HORIZON-MISS-2027-02-CANCER-01

This call focuses on deepening the functional understanding of tumour heterogeneity during cancer initiation, progression, and relapse. It prioritises high-impact areas including paediatric cancers, rare tumours, and cancers with limited treatment options or low survival rates. Proposals are expected to leverage cutting-edge technologies—such as single-cell studies, spatial gene mapping, and liquid biopsies—to identify precise therapeutic targets and develop next-generation, genomically-informed treatments. Successful projects will integrate AI tools and computational modelling to manage complex, multimodal clinical data, ensuring all results contribute to the UNCAN.eu research data platform. Learn more

Read More
Clinical Research by Comprehensive Cancer Infrastructures for the Benefit of Patients with Common Cancers
HORIZON-MISS-2027-02-CANCER-02

This call focuses on conducting high-impact clinical research within the framework of Comprehensive Cancer Infrastructures (CCIs) to improve outcomes for patients with common cancers (such as breast, lung, colorectal, and prostate). The objective is to embed innovative research directly into clinical practice, facilitating the rapid translation of diagnostic and therapeutic advancements into routine care. Projects must focus on at least one of the following areas: innovative diagnostics; radiotherapy, surgery, or chemotherapy; the development of therapeutic cancer vaccines for patients with early-stage, advanced, metastatic, or minimal residual disease; or the implementation of clinical practice guidelines for diagnosis and treatment in countries with limited or no existing CCIs. Learn more

Read More
Predictive Biomarkers of Disease Progression and Treatment Response Using AI
HORIZON-HLTH-2027-02-TOOL-01-two-stage
This call focuses on the clinical development of multimodal predictive biomarkers to improve disease progression assessment and treatment response for chronic non-communicable diseases (excluding cancer). The initiative seeks to address the complexity of multifactorial diseases characterised by high patient heterogeneity. Proposals are expected to adapt established AI methodologies to integrate diverse data—including molecular, imaging, and Real-World Data (RWD)—to provide clinicians with more accurate tools for personalised therapeutic interventions. The scope includes the mapping and evaluation of existing candidate biomarkers, the application of trustworthy AI to identify high-accuracy predictive indicators, and the establishment of a biomarker validation platform using independent disease cohorts. Learn more
Read More
Virtual Human Twins (VHTs) for Integrated Clinical Decision Support in Prevention and Diagnosis
HORIZON-HLTH-2027-03-TOOL-04
This call focuses on the development and validation of Virtual Human Twins (VHTs) to provide integrated clinical decision support for the prevention and diagnosis of high-burden diseases. By creating multiscale, multi-organ digital representations of individual patients, the initiative aims to move beyond traditional diagnostic methods toward highly personalised medicine. Proposals are expected to deliver robust VHT solutions that can be seamlessly integrated into existing clinical care pathways, offering clinicians predictive insights to guide early intervention and optimise treatment strategies. Key activities include developing multiscale digital models that integrate diverse health data, validating VHT performance in real-world clinical settings, and ensuring interoperability with other digital health tools. Learn more
Read More
Advancing Bio-Printing of Living Cells for Regenerative Medicine
HORIZON-HLTH-2027-03-TOOL-02
This call focuses on advancing the state-of-the-art in bio-printing technologies to create functional, living tissue constructs for regenerative medicine. The objective is to move beyond simple structures toward the production of complex, multi-cellular tissues that mimic the physiological properties and functions of native human organs. Proposals should prioritise improving the precision, scalability, and viability of bio-printed materials, ensuring they can be successfully integrated into clinical applications for tissue repair and replacement. Key activities include optimising bio-ink formulations for enhanced cell survival and differentiation, validating the long-term function of printed constructs in clinically relevant models, and developing automated manufacturing processes to ensure reproducibility. Learn more
Read More
Decentralised, Federated and Sustainable AI Data Processing
HORIZON-CL4-2027-04-DATA-03
This call focuses on developing innovative approaches, tools, and techniques for decentralised, federated, and sustainable AI data processing. It aims to overcome the bottlenecks of centralised AI—such as energy constraints, compute capacity, and latency—by leveraging distributed resources across the Cloud-Edge-HPC continuum. Proposals should support the entire AI lifecycle, integrating heterogeneous hardware architectures (including neuromorphic and quantum) while implementing end-to-end energy efficiency monitoring. Key priorities include ensuring data quality, integrity, and privacy, alongside the optimisation of data transfer volumes in distributed environments. Learn more
Read More
Demand-Side 3C Pilot Demonstrators on Converged Telco Edge Cloud Infrastructure
HORIZON-CL4-2027-04-DATA-08
This call focuses on establishing large-scale pilot demonstrators based on the convergence of Computing, Communication, and Control (3C) within telco edge-cloud infrastructures. The objective is to validate distributed architectures that enable real-time data processing, ultra-low latency, and high reliability for strategic sectors such as smart manufacturing, energy, and autonomous mobility. Projects must demonstrate seamless interoperability between diverse hardware and software providers while integrating AI tools at the network edge, with a strong emphasis on energy efficiency. The initiative seeks to transition technological concepts into tangible solutions that meet complex operational requirements in dynamic industrial environments. Learn more
Read More

Programme Framework

Programme Framework

The Bridging the Horizon consortium-matchmaking process is designed to be efficient and outcome-oriented:

  • Identify Synergies: Before the online session, gain access to our dedicated participant gallery to explore profiles and identify potential consortium partners.
  • Pitch Your Expertise: During the online moderated round table, pitch your expertise directly to experienced researchers and industry professionals in an intimate, collaborative setting.
  • Advance Collaboration: Following the online session, strengthen initial connections and advance them toward concrete proposal development and the structured formation of a consortium as part of the broader Bridges 2026 hybrid initiative.

Impact & Benefits

Access Strategic Knowledge

Gain exclusive expert insights into high-priority Horizon Europe Health funding opportunities.

Collaborate with Proven Partners

Connect with hand-picked academic, industrial, and governmental leaders to build your next winning team.

Validate Your Innovation Concepts

Refine your project ideas through professional feedback and high-level peer review.

Secure Competitive Advantage

Build a robust foundation to increase your success rate in winning strategic Horizon Europe funding.

The Ideal Participant

The Ideal Participant

The target audience of the Bridging the Horizon Health event includes:

  • Academic & Research Institutions: Researchers and labs focusing on functional genomics, regenerative medicine, 3D bioprinting, mathematical and biophysics-based modeling, data science & bioinformatics.
  • Hospitals & Clinical Settings: Comprehensive Cancer Infrastructures (CCIs), specialised medical departments (oncology, chronic disease management, regenerative medicine), and clinical research organisations.
  • Industry: Companies and startups in biotech, bio/tissue engineering, med-tech, AI & digital health, software engineering, and pharmaceutical R&D.
  • Data Holders: HMOs and biobanks.
  • Social Science and Humanities (SSH) Disciplines: Patient representative organisations, SSH experts.
  • Regulatory & Compliance Experts

* The programme is not suitable for consultants

It’s Time to Build Your Next Consortium

7 May
11 June
16 June
19 June
23 June
Applications Open
Applications Close
Selection Notification
Pitch Submission Deadline
Online Round Table
7 May

Applications Open

7 May
11 June

Applications Close

11 June
16 June

Selection Notification

16 June
19 June

Pitch Submission Deadline

19 June
23 June

Online Round Table

23 June

From Connection to Action:

Bridges Thessaloniki

Taking place on 24–25 November, this in-person consortium-building event moves from initial introductions to concrete partnership development.
Programme Highlights
  • Collaborative Proposal Drafting: Hands-on working sessions to move beyond abstract ideas and begin shaping the proposal’s core content, translating project concepts into clearly defined objectives, activities, and impact narratives.
  • Consortium Organisation & Structure: Practical sessions to map out partner roles, work package distribution, and internal management frameworks, creating a solid operational foundation for the consortium.
  • Expert-led Masterclasses: Targeted workshops on effective consortium formation and project coordination skills.
  • Strategic Insights: Direct guidance from Horizon Europe experts on proposal excellence and the critical ‘dos and don’ts’ for a successful bid.
Mark Your Calendar
  • Call for Applications Opens: 1 July 2026
  • Call for Applications Closes: 15 September 2026
  • Bridges Thessaloniki: 24-25 November 2026

* The Bridging the Horizon round table acts as a momentum builder for the in-person Bridges event in Thessaloniki (November 2026), however, participation in each event remains independent, and a separate call for the Thessaloniki programme will open in July. We encourage you to apply for both programmes.

Learn More

Co-Led By:

ISERD, the Israel-Europe Research and Innovation Directorate, operates under the Israel Innovation Authority and supports Israeli participation in European research and innovation programmes. As Israel’s official National Contact Point for the EU Framework Programmes, ISERD helps organisations access funding, build international partnerships, and join European consortia.

As a global outreach location of the European Institute of Innovation and Technology (EIT), EIT Hub Israel creates synergies between the EIT community and the Israeli innovation ecosystem, supporting the growth of innovative start ups and increasing EU-Israel collaborative projects.

Since 2021, EIT Hub Israel has been actively operating in the Horizon Europe space through its consortium-building programmes Bridging the Horizon and Bridges, bringing together 1,108 participants from across Europe and Israel, delivering 22 events, presenting 60 open calls, and facilitating the formation of 25 cross-border consortia across health, energy, civil security, food-tech, smart mobility, and aquaculture.

FAQ

No. Bridging the Horizon is a 100% virtual programme. It consists of moderated, online matchmaking round tables designed to facilitate flexible participation for stakeholders across Europe and Israel.

However, it serves as an essential foundational stage for our wider hybrid consortium building initiative, which includes also an in-person consortium development programme in Thessaloniki on 24-25 November.

While the virtual session provides the critical groundwork, please note that the Thessaloniki phase requires a separate application and selection process.

You will engage with potential consortium partners, industry experts, leading researchers from RTOs (Research and Technology Organisations), and seasoned project coordinators who have successfully led Horizon Europe submissions.

We are seeking senior decision-makers (Chief Technology Officers, Chief Medical Officers) from the med-tech industry; innovation leads from university hospitals and other leading academic institutes; Principal Investigators in medical AI and genomics from top research clusters; alongside strategic representatives from key European health associations, to drive large-scale clinical validation and adoption.​

The programme focuses on five high-impact 2027 Horizon Europe calls within the Health cluster:

  • Functional Genomics: Leveraging functional genomics to reveal novel targets for cancer treatment.
  • Clinical Research by CCIs: Benefitting patients with common cancers.
  • Predictive Biomarkers: Using AI to develop predictive biomarkers of disease progression and treatment response.
  • Virtual Human Twins: Integrated clinical decision support in prevention and diagnosis.
  • Regenerative Medicine: Advancing bio-printing of living cells.

No. While the online round table and the Bridges Thessaloniki programme are designed to complement each other, they are independent components with separate application and selection processes. However, we highly recommend participating in both, as the online round table establishes the initial connections necessary for intensive proposal development in Thessaloniki. Notably, participation in the virtual session is a weighted component of our evaluation framework and selection criteria for the Thessaloniki programme; applicants who attend the online session will be awarded additional points within the selection criteria for the Thessaloniki programme.

All applications will be reviewed by EIT Hub Israel. Shortlisted applicants may be invited for a brief interview to support the evaluation process.

If you wish to submit a query about the selection process, you can email Maytal at: maytal.perlman@eithubisrael.eu.

Participants will leave with a vetted network of potential partners, a deeper understanding of the technical requirements of the selected calls, and professional feedback on their project concepts to strengthen future submissions.

Participation is free of charge for selected applicants. However, it requires a significant commitment to the consortium-building process and active participation in the scheduled session.

Do you have any questions? Get in touch with us at
Send a Message
Apply Now

search

CONTACT US

EIT HUB ISRAEL

Full access to the community network

Connect & Experience offers more than training. The C&E community network is an active EU online and offline community offering easy access to opportunities, curated content, matchmaking, soft landing services, and support. The community provides a space for community builders from Europe and Horizon Europe associated countries to interact, share best practices, and collaborate to enhance your startup community.

SHOW MORE
To read the full report, please enter your email.
 
*For the best experience, we highly recommend reading the report on your desktop and not your mobile.
To read the full report and receive a link to download it, please enter your email.
 
*For the best experience, we highly recommend reading the report on your desktop and not your mobile.

Access to Healthcare

The Health not The Death is a fundamental human right. A healthy population is not to be seen as human and social capital, an input, or by-product, towards economic growth. Alongside a healthy and sustainable environment, a solidarity, a healthy population must be the ultimate goal especially nowadays in helping Ukrainian migrants with cancer and their families.

Solidarity in health is a cornerstone of EU health policy. There are wide disparities in many health outcomes across the region and those outcomes. The access rules dramatically affect healthcare systems which are at the forefront of the migrant way, the people who are searching for help and the way how we could enhance and support their healthier and wellbeing status.

In order to ensure their access to care and continued cure in need, the probability of receiving a timely diagnosis and of surviving differs greatly from country to country where they are now. There is lack of information, help and inequalities in access. People need help in navigating cancer knowledge, diagnostics, secondary monitoring and prevention, way of treatments, and care.

Shifting our mindset, supporting healthcare connectivity, removing inequalities overall across Europe is our mission and even more now in a time of crisis, helping the Ukrainian people dealing with cancer is a good place to begin this transformative revolution.

1) Whether we have a chance to foster more holistic and integrated approaches to receive information and care, by supporting coordination and maximising an enabling and health-enhancing effect of care across services from different countries?

2) Whether actions should address the social determinants of health, the countries where they are now, the health need which they have, the social and language barriers are the conditions which have to be taken into consideration in a coordinated manner?

How might we improve patients and /or people who seek healthcare support, access to healthcare services at an EU & the Member States Healthcare systems level? Especially in a time of crisis in Europe.

How might we support refugees fleeing from their countries by navigating them to medical centres to receive best available care?  

SHOW MORE

Predictive Treatment

Precision medicine aims to personalise care for every individual. Nongenomic and genomic determinants, combined with information from patient symptoms, clinical history, and lifestyle (nutrition, physical activity, stress etc.), can facilitate personalised diagnosis and prognostics. Yet this goal requires access to massive amounts of data which may come from different structured and unstructured sources; these can be our medical records, laboratory testing, a range of medical devices as well as from the patient himself. AI & ML can combine input from these multiple sources, analyse them and identify biomarkers that can support health professionals make more informed decisions. The convergence of precision medicine with the advanced AI capabilities will improve the ability to personalise care – improve diagnosis, risk prediction as well as therapy planning.  

HCPs want to better predict treatment response, given uncertainty around which treatment to prescribe to which patient and when to prescribe. How do we risk assess the patients, match them with the right treatment (personalised). How can we transform the wealth of data and link it to the predictive nature of how the patient will respond?

SHOW MORE

Patient Journey Navigation

Being diagnosed with cancer is overwhelming and comes as a blow. Patients may feel on a roller coaster of emotions—they are scared, lost & confused not knowing what to expect, who to refer to, what to do and how to tell their loved ones.  They directly refer to “Dr. Google” to look for information about their disease, possible treatments, QoL strategies with the aim to have better understanding of their disease and learn how to better cope with their disease & treatment, yet information is not always valid, accessible, nor personalised or tailored to the patient’s status and needs therefore left with huge amounts of non-relevant information. Coming to the doctor, the physician’s time is limited and mostly focusing on the physical aspects of the disease & treatment, not leaving much time to ask questions nor discuss more holistic aspects of the disease such as emotional, psychological, social aspects. The patient (& caregiver in many cases) leaves the room with unanswered questions, doesn’t remember much of what has been said, and feels he is not heard, nor seen as a whole.

The need for navigating this journey along the emotional psychological stress is overwhelming & patients and their caregivers look for support (case manager/companion/partner) to help manage their disease holistically – starting from having clarity around their disease and treatment by having access to reliable and personalised information during their journey as well as having an integrated holistic care system , supporting them and their loved ones to navigate through the different aspects of their disease – medical, emotional, logistical, psychological, social, rights.

How can we support patients to navigate through the complexity of their disease and treatment ensuring they have validated holistic information about their disease journey & treatment and be empowered to  effectively manage their care 

SHOW MORE

Peer-to-Peer Medical Exchange

As medical events pivoted from conference centres and meeting rooms to the virtual settings, learning opportunities continue. Lectures and presentations are translated to the new digital world, yet the ability to connect and network is relatively lost. Peer interaction is essential not only for information exchange but to share practical insights, allows consultation & in-person experience cross country and across borders leading to better disease management.

This peer-based learning/ consultation is highly valued amongst practising clinicians and was generally achieved when HCPs and KOLs met their peers in national & Intl conferences, group debates, advisory boards and even during quick corridor conversations. Attempting to replicate these in-person experiences into the digital space creates challenges and are not effective nor impactful as face-to-face engagements. 

How might we improve HCP medical exchange enabling physicians to easily communicate, consult, exchange opinions leveraging individual experts & centres of excellence knowledge, experiences, and practices?

How can we leverage the technological expertise to allow HCPs to connect with leading experts across countries to get advice / counselling for their cases?

SHOW MORE

Application for 2022Calling2Scale is closed.
Interested in participating in the next cohort?
Email maayan.sharon@eithubisrael.eu

Privacy Overview
EIT Global Outreach

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Necessary cookies enable core functionality such as page navigation and access to secure areas. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.

3rd Party Cookies

This website uses Google Analytics, Yandex, Facebook pixel, and LinkedIn Insight Tag to collect anonymous information such as the number of visitors to the site and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Powered by  GDPR Cookie Compliance